Home > Press > ETPL celebrates a decade of bringing science to market, announces focus areas beyond 2012: Innovation Clusters, or Hotspots, to include Diagnostics, Anti-Microbials, Bio-imaging, Printed Electronics and Business Analytics
Abstract:
ETPL, the technology transfer arm of A*STAR, today announced it has earmarked five Innovation Clusters or Hotspots aimed at strengthening Singapore's research and business ecosystem.
Its goal: to drive a consistent pipeline of technologies for commercialisation as well as build clusters of industries around these Hotspots. Spanning both the Biomedical Science and Science & Engineering sectors, the focus areas are: Diagnostics, Anti-Microbials, Bio-imaging, Printed Electronics and Business Analytics.
These areas were selected based on market potential as well as the strength and leadership of A*STAR's research in those areas. Patent strength in technologies that support the Hotspots was also a factor, along with the speed at which each Hotspot is likely to mature, deliver results, and reach leadership position.
"Technology transfer isn't just about numbers and revenue," said ETPL CEO Philip Lim. "ETPL's role includes creating new jobs, transforming industry and giving Singapore businesses a competitive edge. The world beyond 2012 will rely increasingly on ecosystems of partnership for success. It is a world of collaborative business models in which marketing savvy and IP prowess go hand in hand. ETPL will continue to build on our results and partnerships to grow these ecosystems."
ETPL was set up in January 2002 to commercialise the outcomes of A*STAR's research institutes and to consolidate the research organisation's patent portfolio. Today, ETPL:
• Manages more than 3,500 active patents and applications
• Has granted more than 400 licences for A*STAR technologies - with expected revenues of more than $500 million
• Has spun off more than 40 start-ups
• Serves diverse industries including biotechnology, ICT, manufacturing, shipping, and more
In 2011 alone, ETPL achieved 40% of MTI's 5-year targets for licences as well as Realised Imputed Commercial Value, defined as the revenue the licensee is expected to generate from incorporating the technology. Its patent utilisation rate tripled year-on-year and it saw double-digit growth in the number of A*STAR start-ups.
ETPL is a one stop resource that bridges the gap between research and market. Its officers work extremely closely with their A*STAR counterparts to identify market opportunities and promising research as well as work with scientists and industry players to create licensing and spin-off opportunities.
ETPL identifies A*STAR technology that businesses can license and build into their products and/or improve processes. It also works within A*STAR and its ecosystem to build an environment for entrepreneurship to thrive as well as engage the community via outreach opportunities such as Distinguished Technopreneur Speaker Forum series, Industry Forums, public-private collaborations.
"Moving ahead, we will continue our focus on integrative industry engagement and look to becoming international in our outlook as well as commandeering industry leadership for all technology transfer services," said Philip.
####
About ETPL
ETPL is the commercialization arm of the Agency for Science, Technology and Research (A*STAR). Its mission is to support A*STAR in transforming the economy through commercializing R&D. Formerly referred to as Exploit Technologies, the organisation enhances the research output of A*STAR scientists by translating their inventions into marketable products or processes.
Through licensing deals and spin-offs with industry partners, ETPL is a key driver of technology transfer in Singapore. It actively engages industry leaders and players to commercialise A*STAR’s technologies and capabilities, bridging the gap from Mind to Market. ETPL’s charter is to identify, protect and exploit promising intellectual property (IP) created by A*STAR’s research institutes.
For more information, please click here
Contacts:
Geraldine Kan
Phone: (65) 8157 8832
Amanda Lee
Phone: (65) 6478 8443
Copyright © ETPL
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
Turning up the signal November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Printing/Lithography/Inkjet/Inks/Bio-printing/Dyes
Presenting: Ultrasound-based printing of 3D materials—potentially inside the body December 8th, 2023
Simple ballpoint pen can write custom LEDs August 11th, 2023
Disposable electronics on a simple sheet of paper October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||